![John Cullity](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Cullity
Presidente en HaemaLogiX Pty Ltd. .
Fortuna: 8 M $ al 31/05/2024
Cargos activos de John Cullity
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Biosynergy Partners LLC | Corporate Officer/Principal | 01/09/2013 | - |
Theraly Fibrosis, Inc.
![]() Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Director/Miembro de la Junta | 01/09/2016 | - |
HaemaLogiX Pty Ltd.
![]() HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Presidente | - | - |
Director/Miembro de la Junta | 01/01/2015 | - | |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
Historial de carrera de John Cullity
Antiguos cargos conocidos de John Cullity.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
RACE ONCOLOGY LIMITED | Director/Miembro de la Junta | 20/04/2023 | 22/08/2023 |
Presidente | 06/03/2020 | 20/04/2023 | |
Ceramedix Holdings LLC | Director/Miembro de la Junta | 01/07/2015 | 01/03/2020 |
Torreya Partners LLC
![]() Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2010 | 01/01/2017 |
Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | - | - |
Merk Sharp & Dohme (Holdings) Pty Ltd.
![]() Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Corporate Officer/Principal | - | - |
░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de John Cullity.
London School of Economics & Political Science | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
The University of Western Australia | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Australia | 6 |
Reino Unido | 3 |
Operativa
Corporate Officer/Principal | 6 |
Director/Board Member | 4 |
Chairman | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 5 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
RACE ONCOLOGY LIMITED | Health Technology |
Empresas privadas | 8 |
---|---|
Biosynergy Partners LLC | |
Sanofi-Synthelabo, Inc. | Health Technology |
Merk Sharp & Dohme (Holdings) Pty Ltd.
![]() Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Health Technology |
Sanofi-Aventis Healthcare Pty Ltd. | |
Torreya Partners LLC
![]() Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Theraly Fibrosis, Inc.
![]() Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
HaemaLogiX Pty Ltd.
![]() HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Health Technology |
Ceramedix Holdings LLC |
- Bolsa de valores
- Insiders
- John Cullity
- Experiencia